UK markets closed

Royalty Pharma PLC (RPD.BE)

Berlin - Berlin Delayed price. Currency in EUR
Add to watchlist
26.31+0.12 (+0.46%)
At close: 08:08PM CEST
Full screen
Previous close26.19
Open26.04
Bid25.82 x N/A
Ask26.36 x N/A
Day's range26.03 - 26.39
52-week range24.12 - 32.01
Volume60
Avg. volume0
Market capN/A
Beta (5Y monthly)N/A
PE ratio (TTM)N/A
EPS (TTM)N/A
Earnings date06 Aug 2024 - 12 Aug 2024
Forward dividend & yieldN/A (N/A)
Ex-dividend dateN/A
1y target estN/A
  • Simply Wall St.

    Only Four Days Left To Cash In On Royalty Pharma's (NASDAQ:RPRX) Dividend

    Regular readers will know that we love our dividends at Simply Wall St, which is why it's exciting to see Royalty...

  • GuruFocus.com

    Royalty Pharma PLC (RPRX): A Strategic SWOT Insight

    Decoding the Financials and Future Prospects in Royalty Pharma's Latest 10-Q Filing

  • GlobeNewswire

    Royalty Pharma Reports First Quarter 2024 Results

    Royalty Receipts growth of 14% driving Portfolio Receipts of $717 millionNet cash provided by operating activities of $665 millionFull year 2024 guidance confirmed: Portfolio Receipts expected to be $2,600 to $2,700 millionCommitment to grow dividend by mid-single digit percentage annually NEW YORK, May 09, 2024 (GLOBE NEWSWIRE) -- Royalty Pharma plc (Nasdaq: RPRX) today reported financial results for the first quarter of 2024 and confirmed full year 2024 guidance for Portfolio Receipts. “We con